Citation Impact
Citing Papers
A review of uncertainty quantification in deep learning: Techniques, applications and challenges
2021 Standout
Optical coherence tomography angiography
2017 Standout
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
2015 Standout
Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature
2013 Standout
Effect of pegaptanib sodium 0.3 mg intravitreal injections (Macugen) in intraocular pressure: posthoc analysis from V.I.S.I.O.N. study
2014
Twenty-four-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-Related Macular Degeneration
2014
Screening Examination of Premature Infants for Retinopathy of Prematurity
2018 Standout
Aptamers as targeted therapeutics: current potential and challenges
2016 Standout
Age-related macular degeneration
2018 Standout
Investigating the choriocapillaris and choroidal vasculature with new optical coherence tomography technologies
2015
The Relationship Between Axial Length and Choroidal Thickness in Eyes With High Myopia
2012
Explainable artificial intelligence (XAI) in deep learning-based medical image analysis
2022
OUTER RETINAL ATROPHY AFTER REGRESSION OF SUBRETINAL DRUSENOID DEPOSITS AS A NEWLY RECOGNIZED FORM OF LATE AGE-RELATED MACULAR DEGENERATION
2013
Type 2 diabetes mellitus
2015 Standout
Intraocular Pressure in Eyes Receiving Monthly Ranibizumab in 2 Pivotal Age-Related Macular Degeneration Clinical Trials
2014
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
The Kallikrein-Kinin System in Diabetic Retinopathy
2014
Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy
2015 StandoutNobel
Cardiovascular Events and Bleeding Risk Associated With Intravitreal Antivascular Endothelial Growth Factor Monoclonal Antibodies
2014
Explainable Artificial Intelligence (XAI): What we know and what is left to attain Trustworthy Artificial Intelligence
2023 Standout
IMPROVING THE AGE-RELATED MACULAR DEGENERATION CONSTRUCT
2017
Neurodevelopmental Outcomes Following Bevacizumab Injections for Retinopathy of Prematurity
2016
Works of Luís Mendonça being referenced
Vascular endothelial growth factor plasma levels before and after treatment of neovascular age‐related macular degeneration with bevacizumab or ranibizumab
2011
SEGREGATION OF OPHTHALMOSCOPIC CHARACTERISTICS ACCORDING TO CHOROIDAL THICKNESS IN PATIENTS WITH EARLY AGE-RELATED MACULAR DEGENERATION
2012
Effect on Intraocular Pressure in Patients Receiving Unilateral Intravitreal Anti-Vascular Endothelial Growth Factor Injections
2011
DR|GRADUATE: Uncertainty-aware deep learning-based diabetic retinopathy grading in eye fundus images
2020
Sustained Increased Intraocular Pressure Related to Intravitreal Antivascular Endothelial Growth Factor Therapy for Neovascular Age-related Macular Degeneration
2011
Arterial Thromboembolic Events in Patients with Exudative Age-Related Macular Degeneration Treated with Intravitreal Bevacizumab or Ranibizumab
2011